Assessing the Awareness and Adoption of Lassa Fever Prevention Practices in Endemic States of Nigeria: Implication for Public Health Interventions

Download Article

DOI: 10.21522/TIJPH.2013.13.03.Art014

Authors : Inigbehe Babatunde Oyinloye, Paul Olaiya Abiodun

Abstract:

The knowledge and awareness of the risks associated with Lassa fever (LF) are still shallow in some endemic communities and even among some HCWs. This study aimed to evaluate the awareness and adoption of LF prevention practices in select endemic states of Nigeria vis-à-vis the public health implications. This research was a cross-sectional study with two phases: observation and desk review of other related data from study communities where situation reports from the Federal Ministry of Health and the CDC from 2012-2022 were reviewed and analysed. There was a high level of awareness (95.0%) and knowledge of the risk factors (93.7%) of LF, with gender playing a pivotal role as the females had more awareness likelihood (p<0.05). The age, geographical location, and socio-economic class of the respondents do not have any effect on the awareness of LF (p>0.05). There was no association between gender, age, and geographical location and the risk factor knowledge for LF (p>0.05); however, it showed that the socio-economic class directly affected the risk factors awareness (p<0.05). Gender should be considered in raising LF awareness, channeling effort into improving the socio-economic class of people to increase LF knowledge which will consequently reduce the devastating public health impact.

References:

[1].   Richmond, J. K., & Baglole, D. J., 2003, Lassa fever: epidemiology, clinical features, and social consequences. BMJ : British Medical Journal, 327(7426), 1271. https://doi.org/10.1136/BMJ.327.7426.1271

[2].   WHO., 2023, May 1, Disease Outbreak News; Lassa Fever – Nigeria. https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON463

[3].   Duvignaud, A., et al., 2021, “Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study,” Lancet. Glob. Heal., 9(4), pp. e469–e478, Apr. 2021, doi: 10.1016/S2214-109X(20)30518-0.

[4].   ReliefWeb, 2024, January 25, Tackling the spread of Lassa fever in Nigeria - Nigeria | ReliefWeb. https://reliefweb.int/report/nigeria/tackling-spread-lassa-fever-nigeria

[5].   Ogbole, M. E., Ameh, J. A., Mailafia, S., Olabode, O. H., & Adah, B. J., 2022, Occurrence of Lassa Fever Virus Infections and Control Efforts in Nigeria. Hosts and Viruses, 9(1). https://doi.org/10.17582/JOURNAL.HV/2022/9.1.7.11

[6].   Naeem, A., Zahid, S., Hafeez, M. H., Bibi, A., Tabassum, S., & Akilimali, A., 2023, Re‐emergence of Lassa fever in Nigeria: A new challenge for public health authorities. Health Science Reports, 6(10). https://doi.org/10.1002/HSR2.1628

[7].   Usuwa, I. S., Akpa, C. O., Umeokonkwo, C. D., Umoke, M., Oguanuo, C. S., Olorukooba, A. A., Bamgboye, E., & Balogun, M. S., 2020, Knowledge and risk perception towards Lassa fever infection among residents of affected communities in Ebonyi State, Nigeria: Implications for risk communication. BMC Public Health, 20(1), 1–10. https://doi.org/10.1186/S12889-020-8299-3/TABLES/5

[8].   WHO, 2024, Lassa fever. https://www.who.int/health-topics/lassa-fever#tab=tab_1

[9].   Lobato, L., Bethony, J. M., Pereira, F. B., Grahek, S. L., Diemert, D., & Gazzinelli, M. F., 2014, Impact of gender on the decision to participate in a clinical trial: A cross-sectional study. BMC Public Health, 14(1), 1–9. https://doi.org/10.1186/1471-2458-14-1156/TABLES/3

[10].  Thelwall, M., Bailey, C., Tobin, C., & Bradshaw, N. A., 2019, Gender differences in research areas, methods and topics: Can people and thing orientations explain the results? Journal of Informetrics, 13(1), 149–169. https://doi.org/10.1016/J.JOI.2018.12.002

[11].  Grace, J. U. A., Egoh, I. J., & Udensi, N., 2021, Epidemiological trends of Lassa fever in Nigeria from 2015-2021: Areview. Therapeutic Advances in Infectious Disease, 8. https://doi.org/10.1177/20499361211058252

[12].  NCDC, 2024, Lassa Fever Situation Report. https://ncdc.gov.ng/themes/common/files/sitreps/b23b25a04540c4c46323db392ad1941b.pdf

[13].  Johns Hopkins Medicine, “Clinical Research What is It,” 2024, https://www.hopkinsmedicine.org/research/understanding-clinical-trials/clinical-research-what-is-it (accessed Mar. 10, 2024).

[14].  John Hopkins Medicine, 2024, Clinical Research What is It. https://www.hopkinsmedicine.org/research/understanding-clinical-trials/clinical-research-what-is-it

[15].  Bay, A. A., Prizer, L., Orusa, A., Hart, A. R., Perkins, M. M., & Hackney, M. E., 2020, Effects of a Health Education and Research Participation Enhancement Program on Participation and Autonomy in Diverse Older Adults. Gerontology and Geriatric Medicine, 6, 233372142092495. https://doi.org/10.1177/2333721420924952.

[16].  Kernéis, S., Koivogui, L., Magassouba, N., Koulemou, K., Lewis, R., Aplogan, A., Grais, R. F., Guerin, P. J., & Fichet-Calvet, E., 2009, Prevalence and Risk Factors of Lassa Seropositivity in Inhabitants of the Forest Region of Guinea: A Cross-Sectional Study. PLOS Neglected Tropical Diseases, 3(11), e548. https://doi.org/10.1371/JOURNAL.PNTD.0000548.

[17].  Samuel Amoo, O., Ojonugwa Shaibu, J., Salu, O., Idigbe, I., Musa, A. Z., Famokun, G., Ezechi, O., Lawal Salako, B., Omilabu, S., & Audu, R., 2021, Comparative Assessment of Knowledge, Attitude/Practices and Prevention of Lassa fever among Community Dwellers and Contacts of Confirmed Patients in Endemic Areas of Ondo State, Nigeria. European Journal of Medical and Health Sciences, 3(4), 137–144. https://doi.org/10.24018/EJMED.2021.3.4.962

[18].  Cadmus, S., Taiwo, O. J., Akinseye, V., Cadmus, E., Famokun, G., Fagbemi, S., Ansumana, R., Omoluabi, A., Ayinmode, A., Oluwayelu, D., Odemuyiwa, S., & Tomori, O., 2023, Ecological correlates and predictors of Lassa fever incidence in Ondo State, Nigeria 2017–2021: an emerging urban trend. Scientific Reports 2023 13:1, 13(1), 1–15. https://doi.org/10.1038/s41598-023-47820-3

[19].  Awosanya, E. J., 2018, Post-epidemic awareness and knowledge of Lassa fever among residents in affected community in Ibadan, Oyo State, Nigeria. Veterinary World, 11(8), 1059. https://doi.org/10.14202/VETWORLD.2018.1059-1063

[20].  Ossai, E. N., Onwe, O. E., Okeagu, N. P., Ugwuoru, A. L., Eze, T. K., & Nwede, A. S., 2020, Knowledge and preventive practices against Lassa fever among heads of households in Abakaliki metropolis, Southeast Nigeria: A cross-sectional study. Https://Doi.Org/10.1177/2010105819899120, 29(2), 73–80. https://doi.org/10.1177/2010105819899120.

[21].  Gobir, A. A., Ejembi, C. L., Alhaji, A. A., Garba, M. B., Igboanusi, C. J.-C., Usman, B., Umar, Z. Z., & Joshua, I. A., 2020, Knowledge of Lassa Fever Disease and Its Risk Factors Among Rural People in a Nigerian Community. Proceedings 2020, Vol. 45, Page 9, 45(1), 9. https://doi.org/10.3390/PROCEEDINGS2020045009

[22].  Ukwenya, V. O., Fuwape, T. A., Fadahunsi, T. I., & Ilesanmi, O. S., 2021, Disparities in knowledge, attitude, and practices of infection prevention and control of Lassa fever among health care workers at The Federal Medical Centre, Owo, Ondo State, Nigeria. The Pan African Medical Journal, 38(357). https://doi.org/10.11604/PAMJ.2021.38.357.26208

[23].  Adeomi, A. ., Adeoye, A. O., & Adefemi, K., 2017, The high level of awareness of LF among respondents was not matched by appropriate knowledge and attitude. American Journal Of Preventive Medicine And Public Health, 1(1), 27–34. https://doi.org/10.5455/ajpmph.281781

[24].  Tobin, E. A., Asogun, D., Happi, C., Ogbaini, E., & Gunther, S., 2014, Risk factors for Lassa fever in endemic communities of Edo State, Nigeria. International Journal of Infectious Diseases, 21, 258–259. https://doi.org/10.1016/j.ijid.2014.03.958

[25].  Denwigwe, C. P., & Ngwu, M. E., 2022, Personal variables and attitude of youths to Lassa fever preventive practices in Bwari area Council Abuja, Nigeria: Counselling implications. Global Journal of Educational Research, 21(1), 17–25. https://doi.org/10.4314/GJEDR.V21I1.3

[26].  Olayinka, A. T., Elimian, K., Ipadeola, O., Dan-Nwafor, C., Gibson, J., Ochu, C., Furuse, Y., Iniobong, A., Akano, A., Enenche, L., Onoja, M., Uzoho, C., Ugbogulu, N., Makava, F., Arinze, C., Namara, G., Muwanguzi, E., Jan, K., Ukponu, W., Ihekweazu, C., 2022, Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria. PLOS Global Public Health, 2(8), e0000191. https://doi.org/10.1371/JOURNAL.PGPH.0000191

[27].  WHO, 2017, July 31, Lassa fever. https://www.who.int/news-room/fact-sheets/detail/lassa-fever

[28].  Kloc, M., Ghobrial, R. M., Kuchar, E., Lewicki, S., & Kubiak, J. Z., 2020, Development of child immunity in the context of COVID-19 pandemic. Clinical Immunology (Orlando, Fla.), 217, 108510. https://doi.org/10.1016/J.CLIM.2020.108510

[29].  Reuben, R. C., & Gyar, S. D., 2015, Knowledge, attitudes and practices of Lassa fever in and around Lafia, Central Nigeria. International Journal of Public Health and Epidemiology Research, 2(1), 14–19. https://www.researchgate.net/publication/311455681_IJPHER_Knowledge_attitudes_and_practices_of_Lassa_fever_in_and_around_Lafia_Central_Nigeria

[30].  McLeod, C. B., Hall, P. A., Siddiqi, A., & Hertzman, C., 2012, How society shapes the health gradient: work-related health inequalities in a comparative perspective. Annual Review of Public Health, 33, 59–73. https://doi.org/10.1146/ANNUREV-PUBLHEALTH-031811-124603

[31].  Simandan, D., 2018, Rethinking the health consequences of social class and social mobility. Social Science & Medicine (1982), 200, 258–261. https://doi.org/10.1016/J.SOCSCIMED.2017.11.037

[32].  Schroeder, S. A., 2016, American health improvement depends upon addressing class disparities. Preventive Medicine, 92, 6–15. https://doi.org/10.1016/J.YPMED.2016.02.024